FDA Inspection
Asanuma Corporation - Sagamihara FactoryAsanuma Corporation - Sagamihara Factory – FDA Inspection, Feb 2, 2017
Record Details
This FDA Inspection record concerns Asanuma Corporation - Sagamihara Factory, with an inspection on February 2, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Christopher S. Keating
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · e1522335-8487-4b4b-bf31-a639a57c1e20
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002546
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Asanuma Corporation - Sagamihara Factory
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
Other documents for Asanuma Corporation - Sagamihara Factory
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.